Angiotensin II in Liver Transplantation (AngLT-1): A Pilot Randomized Controlled Trial
Latest Information Update: 26 Dec 2023
At a glance
- Drugs Angiotensin II (Primary)
- Indications Hypotension
- Focus Therapeutic Use
- Acronyms AngLT-1
- 20 Dec 2023 Planned End Date changed from 1 Sep 2024 to 1 Sep 2026.
- 20 Dec 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Sep 2025.
- 25 Apr 2022 Status changed from not yet recruiting to recruiting.